New Jersey Better Educational Savings Trust’s AstraZeneca AZN Stock Holding History

New Jersey Better Educational Savings Trust’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,550	Closed	-$210K	–	37
2024 Q1	$210K	Hold	1,550	–	–	0.4%	88
2023 Q4	$209K	Hold	1,550	–	–	0.44%	84
2023 Q3	$210K	Hold	1,550	–	–	0.51%	72
2023 Q2	$222K	Hold	1,550	–	–	0.52%	70
2023 Q1	$215K	Hold	1,550	–	–	0.58%	68
2022 Q4	$210K	Buy	+1,550	New	+$194K	0.62%	67
2022 Q3	–	Sell	-1,550	Closed	-$205K	–	66
2022 Q2	$205K	Hold	1,550	–	–	0.64%	65
2022 Q1	$206K	Buy	+1,550	New	+$186K	0.5%	77

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

New Jersey Better Educational Savings Trust's AZN Position: Q2 2024 in Review

New Jersey Better Educational Savings Trust sold out of AstraZeneca (AZN) in Q2 2024, closing a stake of 1,550 shares — an estimated $210K sold.

New Jersey Better Educational Savings Trust first reported a position in AZN in Q1 2022 and held it in 8 quarters. The position peaked at $222K in Q2 2023. 1,211 funds tracked by Wall St. Rank hold AZN as of Q2 2024.

New Jersey Better Educational Savings Trust reported no remaining AstraZeneca position as of Q2 2024 after selling out during the quarter.
New Jersey Better Educational Savings Trust sold 1,550 AstraZeneca shares in Q2 2024, an estimated $210K.
New Jersey Better Educational Savings Trust first reported a position in AstraZeneca in Q1 2022 and held it in 8 quarters.
New Jersey Better Educational Savings Trust's AstraZeneca position peaked at $222K in Q2 2023.
1,211 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2024.

Based on New Jersey Better Educational Savings Trust's 13F filing for Q2 2024, filed 6 Aug 2024.